RedHill Biopharma Reports Results for the First Quarter of 2014
April 30, 2014 11:00 ET
|
RedHill Biopharma Ltd.
Key financial highlights include:
A first profitable quarter, with net income of $3.4 million, primarily attributed to the $7 million upfront payment received from Salix Pharmaceuticals as part...
RedHill Biopharma Reports 2013 Fourth Quarter and Year-End Financial Results
February 25, 2014 08:00 ET
|
RedHill Biopharma Ltd.
2013 Key Highlights Include:
Strong cash position of over $34 million, as of February 2014, following two private placements in early 2014 and the exercise of warrants, including by directors...